Skip to main content
. 2022 Feb 23;13:800490. doi: 10.3389/fphar.2022.800490

FIGURE 2.

FIGURE 2

Mechanisms of cardiovascular protection of SGLT2 inhibitors mentioned in this article. SGLT2, sodium-glucose cotransporter 2; EPO, erythropoietin; Hb, haemoglobin; Hct, haematocrit; LV, left ventricular.